Feature Flags Shelf-Life Testing Gap in THC Beverages
A testing expert says a production-day certificate of analysis doesn't guarantee the dose consumers get months later, sharpening the case for shared lab standards.

Bright and organized scientific laboratory with various equipment and test tubes.
A certificate of analysis can confirm a THC beverage's potency at production without proving what consumers drink months later.
That's the core argument of an MGRetailer feature published Oct. 6, 2026, which quotes a testing expert on how dose accuracy can erode between the filling line and the shelf. For brands selling dosed drinks, a label that reads right at fill and wrong at the register is a trust problem and a liability problem at once.
The feature's summary says formulation, processing, can liners and storage can each affect potency, and it adds that laboratories need consistent measurement practices. The feed summary doesn't name the expert, so CannIntel is attributing these points to the MGRetailer piece itself.
My read: the COA was built for a different job. It proves a batch met spec at one moment. It was never designed to prove a dose survives a warehouse, a truck and a summer shelf.
Potency can drift at four points between the mixing tank and the consumer's hand.
According to the feature, the variables that matter are these:
- Formulation: how the cannabinoid is carried in the liquid.
- Processing: what happens to the drink during mixing and filling.
- Can liners: the surface where the beverage meets its package.
- Storage: how long and under what conditions the product sits.
None of those show up on a production-day certificate. Not one.
Hemp-derived THC drinks are, in the simplest terms, a water-based product carrying a compound that doesn't love water. That's a hard engineering problem even before a can sits for a few months, and it explains why a single clean number at release can look more reassuring than it should.
Labs need a common ruler before anyone can referee the category.
The feature's headline call for a referee rests on measurement consistency, because a shelf-life testing program only works if two labs looking at the same lot would report comparable results. Without shared practices, brands can shop for the friendlier number, and retail buyers have no way to tell a rigorous COA from a convenient one.
Picture two labs testing the same lot and returning different potency figures. Which certificate goes to the retailer? That isn't a scenario anyone selling a dosed drink should be comfortable leaving to chance.
Here's where the competitive angle gets interesting (and this is analysis, not reporting from the feature). Multistate operators already running compliance-heavy testing in licensed markets could turn that discipline into a sales tool. A beverage brand that hands a buyer a potency curve across shelf life sells differently than one that hands over a one-page COA, and the gap will widen as scrutiny of the category rises.
The hemp-beverage side of the market, meanwhile, has largely grown on speed to shelf. Testing infrastructure has had to catch up with distribution, not the other way around.
Testing through shelf life is cheap insurance against a trust problem the category can't afford.
The feature says manufacturers can use testing throughout production and across shelf life to deliver a dependable dose. In practice, that means treating potency as something to be measured repeatedly over a product's life rather than certified once. The cost of extra testing is real, but it's small next to the cost of a mislabeled product reaching consumers who are counting milligrams.
Stakes aren't abstract here. Consumers who pick up a THC drink in place of alcohol or as a substitute for CBD products are buying predictability. If a second can from the same case feels different from the first, that perception hits the entire category, not just one brand.
For full background on this story, see the CannIntel topic hub on THC beverage testing standards.
The next signal to watch: whether any state regulator or trade group moves from asking for a COA to asking for shelf-life potency data. When that happens, the referee the industry says it wants will have arrived, and brands without a stability program will find out how much it costs to build one on a deadline.
Sources
The cannabis newsletter you forward to your team.
Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.
No spam. Unsubscribe with one click. 21+ only.
Related from Business

St. Louis jury awards $10M in Missouri cannabis ownership fight
A St. Louis jury put a $10 million price on a sprawling Missouri cannabis ownership dispute, and the full record is still thin.

Curaleaf Files Offering Circular Update With Raised Aurora Bid
The amended circular folds Curaleaf's previously announced higher offer into the formal bid document, moving the Aurora pursuit from headline to paperwork.

Spherex Expands Colorado Cannabis Operations With First Acquisition
Forbes reported Spherex's first acquisition, a Colorado expansion move, but the target, price and structure weren't available in the initial signal.
More from the newsroom

Talking Joints Memo Revisits Portugal's 25 Years of Decriminalization
A 25-year retrospective on Portugal's 2001 drug law lands weeks before the US federal hemp redefinition, sharpening the gap between decriminalization and regulation.

Tennessee lawmakers weigh medical marijuana framework, AOL reports
Tennessee legislators are discussing the structure of a possible medical marijuana program, though public details on a bill, sponsor or vote remain thin.

Survey Names Age Group Most Likely to Drive After Cannabis Use
FOX 9 Minneapolis-St. Paul reported new survey data on which age range drives after cannabis use, putting impaired-driving enforcement back in front of regulators.